Literature DB >> 11587873

Antiepileptic drugs: affective use in autism spectrum disorders.

A Di Martino1, R F Tuchman.   

Abstract

Antiepileptic drugs are widely administered to individuals with autistic spectrum disorders. There are several reasons for the use of antiepileptic drugs in autistic spectrum disorders, including the high incidence of epilepsy in these individuals, the anecdotal reports suggesting an improvement of communication and behavior in autistic subjects with epileptic discharges, and the increased awareness that some disruptive behaviors may be manifestations of an associated affective disorder. In this study, data on the current use of antiepileptic drugs in the treatment of autism, and on the association of affective disorders with epilepsy and autism, are reviewed. The evidence supporting the hypothesis that there may be a subgroup of autistic children with epilepsy and affective disorders that preferentially respond to antiepileptic drugs is still very preliminary, and further investigations with double-blind controlled studies are needed. Although the role of antiepileptic drugs at the present time is not established, there is evidence that autism, epilepsy, and affective disorders commonly co-occur, and that they may share a common neurochemical substrate, which is the common target of the psychotropic mechanism of action of different antiepileptic drugs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11587873     DOI: 10.1016/s0887-8994(01)00276-4

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  16 in total

Review 1.  Epilepsy in autism spectrum disorders.

Authors:  Roberto Canitano
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-08-24       Impact factor: 4.785

2.  Autistic spectrum disorder, epilepsy, and vagus nerve stimulation.

Authors:  Mariam Mettry Hull; Deepak Madhavan; Charles M Zaroff
Journal:  Childs Nerv Syst       Date:  2015-04-29       Impact factor: 1.475

3.  Broad clinical involvement in a family affected by the fragile X premutation.

Authors:  Weerasak Chonchaiya; Agustini Utari; Gabriela Marques Pereira; Flora Tassone; David Hessl; Randi J Hagerman
Journal:  J Dev Behav Pediatr       Date:  2009-12       Impact factor: 2.225

4.  Brief report: retrospective case series of oxcarbazepine for irritability/agitation symptoms in autism spectrum disorder.

Authors:  Jessica F Douglas; Kevin B Sanders; M Hannah Benneyworth; Jessica L Smith; Virginia M Dejean; Susan G McGrew; Jeremy Veenstra-Vanderweele
Journal:  J Autism Dev Disord       Date:  2013-05

Review 5.  Autism Spectrum Disorder and Epilepsy: Two Sides of the Same Coin?

Authors:  Shafali Spurling Jeste; Roberto Tuchman
Journal:  J Child Neurol       Date:  2015-09-14       Impact factor: 1.987

Review 6.  The use of newer anticonvulsants in neuropsychiatric disorders.

Authors:  Edward Kim
Journal:  Curr Psychiatry Rep       Date:  2002-10       Impact factor: 5.285

7.  Anti-narcoleptic agent modafinil and its sulfone: a novel facile synthesis and potential anti-epileptic activity.

Authors:  Nithiananda Chatterjie; James P Stables; Hsin Wang; George J Alexander
Journal:  Neurochem Res       Date:  2004-08       Impact factor: 3.996

Review 8.  Intervention for autistic spectrum disorders.

Authors:  Pauline A Filipek; Robin Steinberg-Epstein; Teri M Book
Journal:  NeuroRx       Date:  2006-04

Review 9.  Brain plasticity and disease: a matter of inhibition.

Authors:  Laura Baroncelli; Chiara Braschi; Maria Spolidoro; Tatjana Begenisic; Lamberto Maffei; Alessandro Sale
Journal:  Neural Plast       Date:  2011-07-03       Impact factor: 3.599

10.  Epilepsy in adulthood: Prevalence, incidence, and associated antiepileptic drug use in autistic adults in a state Medicaid system.

Authors:  Lauren Bishop; Kiley J McLean; Eric Rubenstein
Journal:  Autism       Date:  2020-08-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.